A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab.
Chaoyuan KuangKevin QuannAgnes K LimanRoy FryeNawras AlshoubakiMohan RamkumarAndrew D LimanPublished in: Clinical case reports (2020)
Patients with monoclonal gammopathy of renal significance should be treated with clone-directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.